YUHSpace: Dept. of Internal Medicine (내과학교실)

YUHSpace

BROWSE

YUHSpace1. College of Medicine (의과대학)Dept. of Internal Medicine (내과학교실)

Dept. of Internal Medicine (내과학교실)

Researcher List

Keyword Cloud

Journal Categories

Highly Cited Articles

Trastuzumab in combination with chemotherapy versus chemotherapy alone f...

Yung-Jue Bang ; Eric Van Cutsem ; Andrea Feyereislova ; Hyun C Chung ; Lin Sh... LANCET, Vol.376(9742) : 687-697, 2010

Osimertinib in Untreated EGFR-Mutated Advanced Non–Small-Cell Lung Cancer

Jean-Charles Soria ; Yuichiro Ohe ; Johan Vansteenkiste ; Thanyanan Reungwetw... NEW ENGLAND JOURNAL OF MEDICINE, Vol.378(2) : 113-125, 2018

Durvalumab after Chemoradiotherapy in Stage III Non-Small-Cell Lung Cancer

S.J. Antonia ; A. Villegas ; D. Daniel ; D. Vicente ; S. Murakami ; R. Hui ; ... NEW ENGLAND JOURNAL OF MEDICINE, Vol.377(20) : 1919-1929, 2017

This table browses all dspace content
Issue Date	Title	Journal Title
2025	Non-invasive risk-based surveillance of hepatocellular carcinoma in patients with metabolic dysfunction-associated steatotic liver disease	GUT
2025	Pan-Asia adapted ESMO Clinical Practice Guideline for the management of patients with newly diagnosed and relapsed epithelial ovarian cancer	ESMO OPEN
2025	Incidence rates of tuberculosis and inflammatory bowel disease in patients with ankylosing spondylitis treated with biologics in Korea	RHEUMATOLOGY
2025	A Response to the Letter to the Editor: "POSEIDON's Missing Piece: Unanswered Questions on PFS Data in High-Risk Subgroups"	JOURNAL OF THORACIC ONCOLOGY
2025	A Phase III Randomized, Double-Blind, Active-Controlled, Multicenter Study on the Efficacy and Safety of Ezetimibe/Atorvastatin/Amlodipine Combination in Patients With Comorbid Primary Hypercholesterolemia and Essential Hypertension	CLINICAL THERAPEUTICS
2025	Predictors of bloodstream infection and its impact on mortality in septic arthritis: A 15-year review	JOURNAL OF MICROBIOLOGY IMMUNOLOGY AND INFECTION
2025	Association of thyroid radiation dose with thyroid dysfunction in patients with locally advanced non-small cell lung cancer treated with concurrent chemoradiotherapy followed by maintenance immunotherapy	LUNG CANCER
2025	The ‘totality of evidence’ and ‘extrapolation’ of SB17, a ustekinumab biosimilar	EXPERT OPINION ON BIOLOGICAL THERAPY
2025	Pericoronary Adipose Tissue Attenuation in Patients with Future Acute Coronary Syndromes: The ICONIC Study	RADIOLOGY-CARDIOTHORACIC IMAGING
2025	Interaction effect of comorbid depression and proactive positivity coping strategy on the 1-year survival of patients with advanced cancer: a nationwide multicentre study in South Korea	BMC PSYCHIATRY
2025	Clinical Significance of Peripheral Arterial Disease Evaluation in Patients with Antineutrophil Cytoplasmic Antibody-Associated Vasculitis	MEDICINA-LITHUANIA
2025	Amivantamab plus lazertinib versus osimertinib as first-line treatment in EGFR-mutated advanced non-small cell lung cancer: MARIPOSA Asian subset	LUNG CANCER
2025	Impact of Left Ventricular Diastolic Pressure Changes on Clinical Outcomes After Transcatheter Aortic Valve Replacement	JOURNAL OF THE AMERICAN HEART ASSOCIATION
2025	Factors Associated with Viral Load Non-Suppression among People Living with HIV on Antiretroviral Therapy in Dili, Timor-Leste	INFECTION AND CHEMOTHERAPY
2025	Aspirin and Clinical Outcomes in Individuals with Incidentally Diagnosed Coronary Artery Stenosis	AMERICAN JOURNAL OF MEDICINE
2025	Attitudes and Experiences With Informed Consent for Percutaneous Coronary Intervention in Korea: A Mixed-Methods Study	JOURNAL OF KOREAN MEDICAL SCIENCE
2025	Noncontrast Magnetic Resonance Imaging vs Ultrasonography for Hepatocellular Carcinoma Surveillance: A Randomized, Single-Center Trial	GASTROENTEROLOGY
2025	Transcriptome sequencing reveals distinct atypical parathyroid tumor subtypes	ENDOCRINE-RELATED CANCER
2025	Impact of physical activities in metabolic dysfunction associated steatotic liver disease, sarcopenia, and cardiovascular disease	DIABETES RESEARCH AND CLINICAL PRACTICE
2025	Plain language summary of MARIPOSA-2: amivantamab-chemotherapy either with or without lazertinib for treatment of non-small-cell lung cancer	FUTURE ONCOLOGY